TBCE and psoriasis: To explore the effect of ENO1 on KCs dysfunction in psoriasis, we established KC models with ENO1 silencing using siRNA or inhibition by an ENO1 inhibitor (ENOBlock, a nonenzymatic active site inhibitor of ENO1) (Supplementary Figure 3A and Figure 3A).